+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Primary Cells Market Share, Size, Trends, Industry Analysis Report, By Type; By End-Use; By Source; By Regions; Segment Forecast, 2021 - 2028

  • ID: 5322010
  • Report
  • April 2021
  • Region: Global
  • 112 pages
  • Polaris Market Research
The global primary cells market size is expected to reach USD 1.79 billion by 2028 according to a new study. The report “Primary Cells Market Share, Size, Trends, Industry Analysis Report, By Type (Hematopoietic, Hepatocytes, Renal, Gastrointestinal, Skin, Lung); By End-Use (Medical, Pharmaceutical & Biotechnology Companies, Research Institutes); By Source; By Regions; Segment Forecast, 2021 - 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing investments in biomedical research coupled with growth in the occurrence of diseases such as cancer drive the growth of the primary cell culture market. Increasing demand for advanced drug development and testing, growing applications in genetic engineering and virology, and stringent regulations regarding animal testing boost the growth of this market.

The significant growth in healthcare and pharmaceutical sectors, technological advancements, and growing use of primary cells in stem cell therapy are some factors expected to provide growth opportunities during the forecast period. The different types of primary cells include hematopoietic, hepatocytes, renal cells, gastrointestinal cells, skin cells, lung cells, and others. There has been a high demand for hematopoietic cells, which are derived from blood and bone marrow.

The demand for human primary cells was high in 2019. Human primary cells exhibit the functional and morphological characteristics of their tissue of origin. Human primary cells are increasingly being used in cancer research, and drug discovery. Other applications driving the growth of this segment include 3D cell culture, drug screening, and toxicity testing, monoclonal antibodies, and genetic engineering.

The increasing use of these cells for treatment and research associated with cancer, coupled with technological advancements drives the market growth. Hematopoietic primary cells are increasingly being used in stem cell therapy, vaccine development, and the study of tissue and organ replacement, thereby boosting the growth of this segment.

The demand for primary cells has increased from pharmaceutical and biotechnology companies for applications such as research and development, drug discovery, testing of new drugs, cosmetics, and chemicals, and analyzing of maximum permissible dosage of new drugs. The increasing investments in biomedical research, coupled with government initiatives support the growth of this segment.

North America dominated the global primary cell culture market in 2020 and is expected to maintain its dominance over the forecast period. Growing advancements in cancer research, significant investment in healthcare services, and the increasing occurrence of cancer-related disorders support market growth in this region. The increasing geriatric population coupled with government initiatives and programs, and emerging healthcare and pharmaceutical sectors fuel growth in this region.

Some major market participants include Cell Biologics, Inc., ZenBio, Inc., Stem Cell Technologies, Sigma-Aldrich, Thermo Fisher Scientific, Cureline, American Type Culture Collection, Cell Applications, Inc., Pelobiotech, Merck KGaA, Axol Bioscience Ltd, Promocell, ALLCells, Lonza Group, AG, and Creative Bioarray.

The publisher segmented the primary cells market report on the basis of source, type, end-use, and region:

Primary Cells Source Outlook
  • Animal Primary Cells
  • Human Primary Cells
Primary Cells Type Outlook
  • Hematopoietic
  • Hepatocytes
  • Renal Cells
  • Gastrointestinal Cells
  • Skin Cells
  • Lung Cells
  • Others
Primary Cells End-Use Outlook
  • Medical
  • Pharmaceutical and Biotechnology Companies
  • Research Institutes
  • Others
Primary Cells Regional Outlook
  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • RoE
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Colombia
  • RoLATAM
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Israel
  • UAE
  • RoMEA
Note: Product cover images may vary from those shown
1. Chapter 1. Introduction
1.1. Report Description
1.2. Stakeholders

2. Chapter 2. Executive Summary
2.1. Market Highlights

3. Chapter 3. Research Methodology
3.1. Overview
3.2. Data Sources

4. Chapter 4. Primary Cells Market Insights
4.1. Primary Cells – Industry snapshot
4.2. Primary Cells Market Dynamics
4.3. Porter’s Five Forces Analysis
4.4. Primary Cells Market PESTLE Analysis
4.5. Value Chain Analysis
4.6. Competitive Ranking Analysis, 2020

5. Chapter 5. Primary Cells Market Assessment by Source
5.1. Introduction
5.2. Animal Primary Cells
5.3. Human Primary Cells

6. Chapter 6. Primary Cells Market Assessment by Type
6.1. Introduction
6.2. Hematopoietic
6.3. Hepatocytes
6.4. Renal Cells
6.5. Gastrointestinal Cells
6.6. Skin Cells
6.7. Lung Cells
6.8. Others

7. Chapter 7. Primary Cells Market Assessment by End-User
7.1. Introduction
7.2. Medical
7.3. Pharmaceutical and Biotechnology Companies
7.4. Research Institutes
7.5. Others

8. Chapter 8. Primary Cells Market Assessment by Geography
8.1. Introduction
8.2. Primary Cells Market – North America
8.3. Primary Cells Market – Europe
8.4. Primary Cells Market – Asia-Pacific
8.5. Primary Cells Market – Latin America
8.6. Primary Cells Market – Middle East and Africa

9. Chapter 9. Competitive Landscape
9.1. Expansion and Product Launch Analysis
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Chapter 10. Company Profiles
10.1. Cell Biologics, Inc.
10.2. ZenBio, Inc.
10.3. Stem Cell Technologies
10.4. Sigma-Aldrich
10.5. Thermo Fisher Scientific
10.6. Cureline
10.7. American Type Culture Collection
10.8. Cell Applications, Inc.
10.9. Pelobiotech
10.10. Merck KGaA
10.11. Axol Bioscience Ltd
10.12. Promocell
10.13. ALLCells
10.14. Lonza Group, AG
10.15. Creative Bioarray

List of Tables
Table 1 Drivers and Inhibitors for Global Market
Table 2 Restraints Global Market
Table 3 Global Primary Cells Market, By Source, 2016 – 2028 (USD Million)
Table 4 Global Primary Cells Market, by Animal Primary Cells, by Region, 2016-2028 (USD Million)
Table 5 Global Primary Cells Market, by Human Primary Cells, by Region, 2016-2028 (USD Million)
Table 6 Global Primary Cells Market, By Type, 2016 – 2028 (USD Million)
Table 7 Global Primary Cells Market, by Hematopoietic, by Region, 2016-2028 (USD Million)
Table 8 Global Primary Cells Market, by Hepatocytes, by Region, 2016-2028 (USD Million)
Table 9 Global Primary Cells Market, by Renal Cells, by Region, 2016-2028 (USD Million)
Table 10 Global Primary Cells Market, by Gastrointestinal Cells, by Region, 2016-2028 (USD Million)
Table 11 Global Primary Cells Market, by Skin Cells, by Region, 2016-2028 (USD Million)
Table 12 Global Primary Cells Market, by Lung Cells, by Region, 2016-2028 (USD Million)
Table 13 Global Primary Cells Market, by Others, by Region, 2016-2028 (USD Million)
Table 14 Global Primary Cells Market, By End-User, 2016 – 2028 (USD Million)
Table 15 Global Primary Cells Market, by Medical, by Region, 2016-2028 (USD Million)
Table 16 Global Primary Cells Market, by Pharmaceutical and Biotechnology Companies, by Region, 2016-2028 (USD Million)
Table 17 Global Primary Cells Market, by Research Institutes, by Region, 2016-2028 (USD Million)
Table 18 Global Primary Cells Market, by Others, by Region, 2016-2028 (USD Million)
Table 19 Global Primary Cells Market, By Geography, 2016 - 2028 (USD Million)
Table 20 North America: Primary Cells Market, by Country, 2016-2028 (USD Million)
Table 21 North America: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 22 North America: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 23 North America: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 24 U.S.: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 25 U.S.: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 26 U.S.: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 27 Canada: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 28 Canada: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 29 Canada: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 30 Europe: Primary Cells Market, by Country, 2016-2028 (USD Million)
Table 31 Europe: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 32 Europe: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 33 Europe: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 34 Germany: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 35 Germany: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 36 Germany: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 37 UK: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 38 UK: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 39 UK: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 40 France: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 41 France: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 42 France: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 43 Italy: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 44 Italy: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 45 Italy: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 46 Spain: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 47 Spain: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 48 Spain: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 49 Rest of Europe: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 50 Rest of Europe: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 51 Rest of Europe: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 52 Asia Pacific: Primary Cells Market, by Country, 2016-2028 (USD Million)
Table 53 Asia-Pacific: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 54 Asia-Pacific: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 55 Asia-Pacific: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 56 China: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 57 China: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 58 China: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 59 India: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 60 India: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 61 India: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 62 Japan: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 63 Japan: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 64 Japan: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 65 South Korea: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 66 South Korea: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 67 South Korea: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 68 Rest of APAC: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 69 Rest of APAC: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 70 Rest of APAC: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 71 Latin America: Primary Cells Market, by Country, 2016-2028 (USD Million)
Table 72 Latin America: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 73 Latin America: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 74 Latin America: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 75 Brazil: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 76 Brazil: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 77 Brazil: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 78 Mexico: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 79 Mexico: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 80 Mexico: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 81 Colombia: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 82 Colombia: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 83 Colombia: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 84 Rest of Latin America: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 85 Rest of Latin America: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 86 Rest of Latin America: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 87 Middle East & Africa: Primary Cells Market, by Country, 2016-2028 (USD Million)
Table 88 Middle East & Africa: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 89 Middle East & Africa: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 90 Middle East & Africa: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 91 Saudi Arabia: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 92 Saudi Arabia: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 93 Saudi Arabia: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 94 South Africa: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 95 South Africa: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 96 South Africa: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 97 Israel: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 98 Israel: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 99 Israel: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 100 UAE: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 101 UAE: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 102 UAE: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 103 Rest of MEA: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 104 Rest of MEA: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 105 Rest of MEA: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)

List of Figures
FIG. 1 Market snapshot
FIG. 2 Market segmentation & scope
FIG. 3 Global Primary Cells market size and growth prospects, 2016 – 2028
FIG. 4 Value chain analysis
FIG. 5 Primary Cells market dynamics
FIG. 6 Key market opportunities - prioritized
FIG. 7 Industry analysis – Porter’s
FIG. 8 PESTEL analysis
FIG. 9 Global Primary Cells market share by Source, 2020 & 2028
FIG. 10 Global Primary Cells market share by Type, 2020 & 2028
FIG. 11 Global Primary Cells market share by End-User, 2020 & 2028
FIG. 12 Global Primary Cells market share by Region, 2020 & 2028
FIG. 13 Competitive environment
FIG. 14 Strategy framework
Note: Product cover images may vary from those shown
Cell Biologics, Inc., ZenBio, Inc., Stem Cell Technologies, Sigma-Aldrich, Thermo Fisher Scientific, Cureline, American Type Culture Collection, Cell Applications, Inc., Pelobiotech, Merck KGaA, Axol Bioscience Ltd, Promocell, ALLCells, Lonza Group, AG, and Creative Bioarray.
Note: Product cover images may vary from those shown
Adroll
adroll